2025 Asco 2025 Abstract 2025 2026. Pisd 20252025 Calendar Patti Andriette MAY 12, 2025 Oral Abstract Presenters deadline to submit their draft slide decks on ASCO's Speaker. Abstract TPS905: Phase 2 trial of immuno-ablation with intrabladder injection of N-803 or intravesical N-803 plus BCG for intermediate-risk non-muscle invasive papillary bladder cancer
ASCO 2023_Poster MESOIMMUNE GFPC from www.g-f-p-c.org
2025 Sponsorship Donors (Gold) 2025 Sponsorship Donors (Silver) MAY 12, 2025 Oral Abstract Presenters deadline to submit their draft slide decks on ASCO's Speaker.
ASCO 2023_Poster MESOIMMUNE GFPC
Uncover how global knowledge-sharing translates to high-quality care for all people affected by cancer worldwide. 2025 ASCO Annual Meeting: Closed: Closed: May 30-June 3, 2025: 2025 ASCO Quality Care. ASCO Breakthrough is your gateway to up-to-the-minute clinical research advances across multiple disease sites
Desk Calendar 20252026 Large 12" x 9",20252026 Wall Calendar 18. Mevrometostat (PF-06821497), an enhancer of zeste homolog 2 (EZH2) inhibitor, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC): A randomized dose-expansion study. 2025 ASCO Abstract Forum for Medical Students and Residents
ASCO Annual Meeting 2023 Precision Oncology Achieving Widespread. 2025 ASCO Annual Meeting: Closed: Closed: May 30-June 3, 2025: 2025 ASCO Quality Care. Mark your calendars for the following abstract dates Abstract Submitter Opens: November 6, 2024 Abstract Submission Deadline: January 28, 2025, at 11:59 PM (ET) Late-Breaking Abstract Submission Deadline: March 5, 2025, at 12:00 PM (Noon) (ET) Abstract Notification Sent to First Author: March 25, 2025 Abstract Withdrawal Deadline: April 6, 2025